Showing results (121-130 of 319) with videos related to

Sort By:
Pageof 32
Drug Metabolism and Pharmacokinetics|October 23, 2004
Decreased expression of glucose and peptide transporters in rat remnant kidneyNobuhiko Nakamura, Satohiro Masuda, Kazushige Takahashi, et al.
Biochemical Pharmacology|October 26, 2005
Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the ratAtsushi Yonezawa, Satohiro Masuda, Kumiko Nishihara, et al.
Biochemical Pharmacology|April 28, 2007
Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3Yuichi Uwai, Hideyuki Motohashi, Yoshie Tsuji, et al.
Drug Metabolism and Pharmacokinetics|July 1, 2005
Transcellular transport of creatinine in renal tubular epithelial cell line LLC-PK1Yumiko Urakami, Naoko Kimura, Masahiro Okuda, et al.
The Journal of Nutrition|May 14, 2010
Identification and comparative functional characterization of a new human riboflavin transporter hRFT3 expressed in the brainYoshiaki Yao, Atsushi Yonezawa, Hiroki Yoshimatsu, et al.
Clinical Pharmacology and Therapeutics|April 3, 2004
Tacrolimus therapy according to mucosal MDR1 levels in small-bowel transplant recipientsSatohiro Masuda, Shinji Uemoto, Maki Goto, et al.
FEBS Letters|July 2, 2003
Na(+)-dependent fructose transport via rNaGLT1 in rat kidneyNaoshi Horiba, Satohiro Masuda, Chiharu Ohnishi, et al.
Pharmacogenetics and Genomics|January 21, 2006
Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipientsMiwa Uesugi, Satohiro Masuda, Toshiya Katsura, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Telaprevir-Induced Renal Adverse Events in Japanese Patients Reported in the PMDA Adverse Drug Reactions Reporting DatabaseAyami Ichida, Hideyuki Motohashi, Asuka Kitano, et al.
Pageof 32